首页> 外文期刊>Italian Journal of Medicine >Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit
【24h】

Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

机译:来源不明的栓塞性卒中:意大利卒中部门的回顾性分析

获取原文
       

摘要

The new clinical construct of embolic stroke of undetermined source (ESUS) suggests that many cryptogenic strokes are related to minor-risk covert embolic cardiac sources or to embolus from non-occlusive plaques in the aortic arch or in the cerebral arteries. The authors analyzed the prevalence of ESUS in a real-life condition in Italy and compared the recurrence rates in cryptogenic strokes, cardioembolic strokes, and ESUS. The authors retrospectively reassessed according to ESUS criteria 391 consecutive admissions in a stroke unit where extensive diagnostic search was routinely performed. Recurrences in each stroke type within a 3-year follow-up period (mean time: 25.44 months - standard deviation: 9.42) were also compared. The prevalence of ESUS in the aforementioned cohort was 10.5%. All ESUS patients received antiplatelet agents. Warfarin was prescribed in 56.9% of cardioembolic strokes. The recurrence rate in ESUS patients was 4.4% per year, slightly higher than in cardioembolic strokes (3.5%) and significantly higher than in cryptogenic non-ESUS (1.2%) (P<0.0001). This is the first description of a cohort of ESUS patients in an Italian stroke unit. Patients with ESUS have a significantly higher risk of recurrence than in those with non-ESUS cryptogenic strokes, and slightly higher than in those with cardioembolic strokes. Results support the hypothesis of a more extensive diagnostic evaluation in cryptogenic strokes and the feasibility of such approach.
机译:来源不明的栓塞性中风的新临床构造(ESUS)表明,许多隐源性中风与低风险隐性栓塞性心脏源或主动脉弓或脑动脉中非阻塞性斑块的栓塞有关。作者分析了意大利在现实生活中的ESUS患病率,并比较了隐源性卒中,心脏栓塞性卒中和ESUS的复发率。作者根据ESUS标准回顾性评估了391例卒中病房的连续入院患者,该病房常规进行了广泛的诊断搜索。还比较了3年随访期内每种卒中类型的复发率(平均时间:25.44个月-标准差:9.42)。在上述队列中,ESUS的患病率为10.5%。所有ESUS患者均接受抗血小板药。华法林的心脏栓塞性卒中占56.9%。 ESUS患者的复发率为每年4.4%,略高于心脏栓塞卒中(3.5%),并且显着高于隐源性非ESUS(1.2%)(P <0.0001)。这是对意大利卒中病房中ESUS患者队列的首次描述。与非ESUS隐源性卒中患者相比,ESUS患者的复发风险明显更高,而心脏栓塞性卒中患者则具有更高的复发风险。结果支持对隐源性卒中进行更广泛的诊断评估的假设以及这种方法的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号